364 related articles for article (PubMed ID: 19318502)
1. Pyrethroid and organophosphate insecticide exposure in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease: an immunohistochemical analysis of tyrosine hydroxylase and glial fibrillary acidic protein in dorsolateral striatum.
Dodd CA; Klein BG
Toxicol Ind Health; 2009 Feb; 25(1):25-39. PubMed ID: 19318502
[TBL] [Abstract][Full Text] [Related]
2. Expression of S-100 protein is related to neuronal damage in MPTP-treated mice.
Muramatsu Y; Kurosaki R; Watanabe H; Michimata M; Matsubara M; Imai Y; Araki T
Glia; 2003 May; 42(3):307-13. PubMed ID: 12673835
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical changes in the mouse striatum induced by the pyrethroid insecticide permethrin.
Pittman JT; Dodd CA; Klein BG
Int J Toxicol; 2003; 22(5):359-70. PubMed ID: 14555407
[TBL] [Abstract][Full Text] [Related]
4. FGF-2 in the MPTP model of Parkinson's disease: effects on astroglial cells.
Otto D; Unsicker K
Glia; 1994 May; 11(1):47-56. PubMed ID: 8070894
[TBL] [Abstract][Full Text] [Related]
5. Neurotoxicity in murine striatal dopaminergic pathways following long-term application of low doses of permethrin and MPTP.
Kou J; Bloomquist JR
Toxicol Lett; 2007 Jul; 171(3):154-61. PubMed ID: 17597311
[TBL] [Abstract][Full Text] [Related]
6. Gender differences on MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in C57BL/6 mice.
Ookubo M; Yokoyama H; Kato H; Araki T
Mol Cell Endocrinol; 2009 Nov; 311(1-2):62-8. PubMed ID: 19631714
[TBL] [Abstract][Full Text] [Related]
7. Astroglial plasticity and glutamate function in a chronic mouse model of Parkinson's disease.
Dervan AG; Meshul CK; Beales M; McBean GJ; Moore C; Totterdell S; Snyder AK; Meredith GE
Exp Neurol; 2004 Nov; 190(1):145-56. PubMed ID: 15473988
[TBL] [Abstract][Full Text] [Related]
8. Estrogen down-regulates glial activation in male mice following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxication.
Tripanichkul W; Sripanichkulchai K; Finkelstein DI
Brain Res; 2006 Apr; 1084(1):28-37. PubMed ID: 16564034
[TBL] [Abstract][Full Text] [Related]
9. Neuronal and astroglial responses to the serotonin and norepinephrine neurotoxin: 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine.
Luellen BA; Miller DB; Chisnell AC; Murphy DL; O'Callaghan JP; Andrews AM
J Pharmacol Exp Ther; 2003 Dec; 307(3):923-31. PubMed ID: 14561848
[TBL] [Abstract][Full Text] [Related]
10. Riluzole (2-amino-6-trifluoromethoxy benzothiazole) attenuates MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in mice.
Araki T; Muramatsu Y; Tanaka K; Matsubara M; Imai Y
Neurosci Lett; 2001 Oct; 312(1):50-4. PubMed ID: 11578843
[TBL] [Abstract][Full Text] [Related]
11. Dietary restriction affects striatal glutamate in the MPTP-induced mouse model of nigrostriatal degeneration.
Holmer HK; Keyghobadi M; Moore C; Menashe RA; Meshul CK
Synapse; 2005 Aug; 57(2):100-12. PubMed ID: 15906381
[TBL] [Abstract][Full Text] [Related]
12. Involvement of cytochrome P450 2E1 in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease.
Vaglini F; Pardini C; Viaggi C; Bartoli C; Dinucci D; Corsini GU
J Neurochem; 2004 Oct; 91(2):285-98. PubMed ID: 15447662
[TBL] [Abstract][Full Text] [Related]
13. Neuronal changes in the nigrostriatal pathway of 1-methyl-4-phenylpyridine-treated mice.
Boatell ML; Mahy N; Cardozo A; Ambrosio S; Tolosa E; Cruz-Sánchez FF
Methods Find Exp Clin Pharmacol; 1992 Dec; 14(10):781-7. PubMed ID: 1363673
[TBL] [Abstract][Full Text] [Related]
14. The MAP kinase cascade is activated prior to the induction of gliosis in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model of dopaminergic neurotoxicity.
O'Callaghan JP; Martin PM; Mass MJ
Ann N Y Acad Sci; 1998 May; 844():40-9. PubMed ID: 9668663
[TBL] [Abstract][Full Text] [Related]
15. Damage to the nigrostriatal system in the MPTP-treated SAMP8 mouse.
Liu J; Wang YY; Liu L; Wang QD; Yuan ZY; Zhang ZX; Gu P; Wang MW
Neurosci Lett; 2008 Dec; 448(2):184-8. PubMed ID: 18977411
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective and anti-inflammatory effects of the adenosine A(2A) receptor antagonist ST1535 in a MPTP mouse model of Parkinson's disease.
Frau L; Borsini F; Wardas J; Khairnar AS; Schintu N; Morelli M
Synapse; 2011 Mar; 65(3):181-8. PubMed ID: 20665698
[TBL] [Abstract][Full Text] [Related]
17. Vigilance states in a parkinsonian model, the MPTP mouse.
Monaca C; Laloux C; Jacquesson JM; Gelé P; Maréchal X; Bordet R; Destée A; Derambure P
Eur J Neurosci; 2004 Nov; 20(9):2474-8. PubMed ID: 15525288
[TBL] [Abstract][Full Text] [Related]
18. Manganese does not alter the severe neurotoxicity of MPTP.
Baek SY; Kim YH; Oh SO; Lee CR; Yoo CI; Lee JH; Lee H; Sim CS; Park J; Kim JW; Yoon CS; Kim Y
Hum Exp Toxicol; 2007 Mar; 26(3):203-11. PubMed ID: 17439923
[TBL] [Abstract][Full Text] [Related]
19. Role of nitric oxide synthase against MPTP neurotoxicity in mice.
Kurosaki R; Muramatsu Y; Michimata M; Matsubara M; Kato H; Imai Y; Itoyama Y; Araki T
Neurol Res; 2002 Oct; 24(7):655-62. PubMed ID: 12392201
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotection in Parkinson models varies with toxin administration protocol.
Anderson DW; Bradbury KA; Schneider JS
Eur J Neurosci; 2006 Dec; 24(11):3174-82. PubMed ID: 17156378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]